Mississippi HB1336 prohibits health care providers from using the buy and bill process for purchasing and administering cancer treatment medications.
Mississippi HB1336 prohibits health care providers from using the buy and bill process for purchasing and administering medications used for cancer treatment. The buy and bill process involves purchasing specialty medications from a distributor, storing them in-house, administering them to patients, and then submitting a claim for reimbursement to a third-party payer. This act aims to change the reimbursement model for cancer treatment medications, effective July 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.